Debevoise Advised agilon health and Clayton, Dubilier & Rice in the $2 Billion Secondary Offering and Repurchase of agilon health Common Stock

18 May 2023

Debevoise & Plimpton LLP has advised agilon health (NYSE: AGL) and Clayton, Dubilier & Rice in the secondary offering of approximately 85 million shares of agilon health common stock by investment funds affiliated with Clayton, Dubilier & Rice and concurrent repurchase of approximately 9.6 million shares of common stock by agilon health. For more information, please see the company’s press release.

The Debevoise team was led by capital markets partners Benjamin Pedersen and Paul Rodel and included associates Nia Goodman, Alice Gu and John Jacob and law clerks Jordana Palgon and Keith Stackhouse.